June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Bayesian modeling to predict long-term visual field test variability in patients with glaucoma
Author Affiliations & Notes
  • Brian C Stagg
    Ophthalmology and Visual Sciences, University of Utah Health, Salt Lake City, Utah, United States
  • Ben Brintz
    University of Utah Health, Salt Lake City, Utah, United States
  • Joshua D Stein
    Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States
  • Rachel Hess
    Population Health, University of Utah Health, Salt Lake City, Utah, United States
  • Kensaku Kawamoto
    Biomedical Informatics, University of Utah Health, Salt Lake City, Utah, United States
  • Alessandro Jammal
    Ophthalmology and Visual Sciences, Duke University, Durham, North Carolina, United States
  • Felipe A Medeiros
    Ophthalmology and Visual Sciences, Duke University, Durham, North Carolina, United States
  • Footnotes
    Commercial Relationships   Brian Stagg None; Ben Brintz None; Joshua Stein None; Rachel Hess None; Kensaku Kawamoto None; Alessandro Jammal None; Felipe Medeiros None
  • Footnotes
    Support  NEI grant K23 EY032577
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 5113. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Brian C Stagg, Ben Brintz, Joshua D Stein, Rachel Hess, Kensaku Kawamoto, Alessandro Jammal, Felipe A Medeiros; Bayesian modeling to predict long-term visual field test variability in patients with glaucoma. Invest. Ophthalmol. Vis. Sci. 2023;64(8):5113.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Visual field monitoring of patients with primary open-angle glaucoma (POAG) is critical to identify disease progression. The statistical power to detect visual field progression from POAG is influenced by long-term test variability, which is not consistent among patients. Predicting long-term test variability for a given patient would help determine the frequency of visual field testing needed for that patient. Baseline visual field mean deviation (MD) is associated with long-term test variability. We hypothesized that a Bayesian model accounting for the association between baseline MD and MD variability would better predict a patient’s long-term visual field test variability than typically used ordinary least-squares (OLS) linear regression.

Methods : We identified patients with POAG and at least 6 Standardized Automated Perimetry (SAP) visual field tests in the Duke Glaucoma Registry. We iteratively divided the study population into 80% training groups and 20% testing groups. For the training groups, we estimated the long-term variability by calculating the OLS variance (mean squared error) for each patient using all their data points. We trained a Bayesian model where the prior for variance was based on a regression equation including baseline MD and baseline MD squared using all observations. For the testing groups, we established ground truth variance for each patient by estimating the OLS variance using all of their data points. We then used only the first 3 observations for the patients to predict the variance using both the Bayesian and OLS models. We compared predicted variances to the ground truth variance by calculating absolute error (AE). We compared mean AE for the Bayesian and OLS models and used bootstrapping to test statistical significance.

Results : We identified 4719 tests of 586 eyes of 434 patients with POAG that met inclusion criteria. The mean AE for the Bayesian estimates was 0.38 dB (standard deviation [SD]: 0.84 dB, median 0.17 dB) compared to 0.91 dB (SD: 1.09 dB, median 0.57 dB, p<0.001) for OLS regression.

Conclusions : Accounting for the association of baseline MD with long-term variability using a Bayesian model improved prediction of long-term variability. This could improve our ability to determine the frequency of visual field testing needed for a given patient with fewer measures than with traditional OLS models and lead to earlier detection of POAG progression.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×